Alfonso M. Duran

Center for Health Disparities and Molecular Medicine Loma Linda University School of Medicine 
"Alfonso Duran"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Aguilar JI, Cheng MH, Font J, et al. (2021) Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia. Elife. 10
Martinez SR, Sanchez-Hernandez ES, Chen X, et al. (2020) Abstract D116: Glucocorticoid receptor interacts with beta-catenin to promote stemness and therapy resistance in prostate cancer cells Cancer Epidemiology, Biomarkers & Prevention. 29
Kuenze G, Duran AM, Woods H, et al. (2019) Upgraded molecular models of the human KCNQ1 potassium channel. Plos One. 14: e0220415
Xia Y, Ledwitch K, Kuenze G, et al. (2019) A unified structural model of the mammalian translocator protein (TSPO). Journal of Biomolecular Nmr
Campbell NG, Shekar A, Aguilar JI, et al. (2019) Structural, functional, and behavioral insights of dopamine dysfunction revealed by a deletion in . Proceedings of the National Academy of Sciences of the United States of America
Durán AM, Salto LM, Câmara J, et al. (2019) Effects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in Mexican-Americans with type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy. 12: 109-120
Woods-Burnham L, Cajigas-Du Ross CK, Love A, et al. (2018) Glucocorticoids Induce Stress Oncoproteins Associated with Therapy-Resistance in African American and European American Prostate Cancer Cells. Scientific Reports. 8: 15063
Cajigas-Du Ross CK, Martinez SR, Woods-Burnham L, et al. (2018) RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance. Oncotarget. 9: 30363-30384
Kharade SV, Kurata H, Bender A, et al. (2018) Discovery, characterization, and effects on renal fluid and electrolyte excretion of the Kir4.1 potassium channel pore blocker, VU0134992. Molecular Pharmacology
Woods-Burnham L, Stiel L, Wilson C, et al. (2018) Physician Consultations, Prostate Cancer Knowledge, and PSA Screening of African American Men in the Era of Shared Decision-Making. American Journal of Men's Health. 1557988318763673
See more...